Drug News June 25, 2026
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
This article from Eli Lilly Press Releases covers: What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management.
Source: Eli Lilly Press Releases • Editorial summary by GLP-1 Price Guide
What This Means for You
This article from Eli Lilly Press Releases covers: What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management.
This article from Eli Lilly Press Releases covers: What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management.
Source: Eli Lilly Press Releases
Original source
Read the full article at Eli Lilly Press Releases